Journal Guide

After proofs are corrected by the authors, articles appear online (fast-track articles on the Ingenta website of the journal) and are immediately citable through their final DOI, without having to wait for pagination. There is a double benefit in this procedure: (i) more rapid publication and citation for the author; (ii) regular articles are not delayed by the publication of special or thematic issues, nor are the early papers of a special issue delayed by slower ones. The latter point was quite relevant in 2008, which has seen the publication of two special issues, one devoted to diamonds, the other dedicated to the memory of Werner Schreyer (with a breadth of coverage that is a fitting reflection of the breadth of interest of this outstanding scientist and strong early supporter of the journal). For the first time in the journal's history, these special issues were graced with thematic covers, a practice that will be maintained in future. Speed of publication is a key issue for authors. In spite of a record number of pages and two special issues, the articles in volume 20 (2008) were published online an average of 9 months after submission, and appeared in print 2 months later, thereby confirming the decisive improvements of 2007. This means that well-organized authors who revise their copy speedily can expect publication online within 5-7 months from submission. With an impact factor steadily above 1.2, this should make the EJM an appealing vehicle for important scientific results.

Journal of clinical and molecular medicine is a quarterly, peer-reviewed journal providing a platform for advances in health care/clinical practices in combination with basic findings in mechanisms of disease pathogenesis to therapy.

Cumulative of clinical practices with an insight for researchers within the community in regard to developing molecular tools and identifying molecular targets for the diagnosis and treatment of a diverse number of human diseases is the primary goal of Journal.

Journal will feature research, review papers, reports, editorials, expert opinion and perspective papers, commentaries, and book reviews.

Journal of clinical and molecular medicine accepts direct submissions from authors: Attach your word file with e-mail and send it to: submissions@oatext.com  alternatively to editor.jcmm@oatext.com

Please, follow the Instructions for Authors. In the cover letter add the name and e-mail address of 5 proposed reviewers (we can choose them or not).

Copyright is retained by the authors and articles can be freely used and distributed by others. Articles are distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published by Journal of clinical and molecular medicine, is properly cited.

The European Journal of Neurology covers all areas of clinical and basic research in neurology. Emphasis is placed on major diseases or large clinical and socio-economic importance (dementia, stroke, epilepsy, headache, multiple sclerosis, movement disorders, and infectious diseases). The journal provides a forum for European activity in clinical neuroscience and medical practice and help strengthen the links between research workers and clinicians in Europe and other parts of the world. In addition to original papers, the journal publishes frequent review and update papers, letters to the editor, book reviews, reports and news. Important articles can be fast-tracked. The journal also publishes the official EFNS taskforce papers, and - in a new development - the journal now includes a CME (Continuing Medical Education) online feature (http://www.blackwellpublishing.com/products/journals/ene/mcqs/). Free Online Access to the European Journal of Neurology.

EJN publishes original research articles and reviews in the broad fields of molecular, cellular, systems, behavioral, and cognitive neurosciences. EJN aims to advance our understanding of the nervous system in health and disease, thereby improving the diagnosis and treatment of neuropsychiatric and neurodegenerative disorders. Papers should present novel results that can be of interest to a broad spectrum of neuroscientists and that were generated by experiments guided by clearly defined aims or hypotheses. Highly specialized articles that provide only limited new insights into the organization and function of the nervous system, or describe results too specialized for a generalist neuroscience journal may be considered outside the scope of EJN. Publish your research in the journal to benefit from:

Highly ranked among journals in its field, the European Journal of Nuclear Medicine and Molecular Imaging provides a forum for the exchange of clinical and scientific information for the nuclear medicine community and allied professions involved in the functional, metabolic and molecular investigation of disease. The journal remains of primary interest to practitioners in the field of nuclear medicine but also reports on original work relating to physics, dosimetry, radiation biology, radiochemistry and pharmacy. Original material examines the field of molecular imaging probes, reporter gene assays, cell trafficking, targeting of endogenous gene expression and antisense methodologies.The Journal publishes in-depth reviews of topical interest, short communications, controversies, interesting images and letters to the Editor. This is the official Journal of the European Association of Nuclear Medicine.

The European Journal of Nutrition publishes original papers, reviews, and short communications in the nutritional sciences. The manuscripts submitted to the European Journal of Nutrition should have their major focus on the impact of nutrients and non-nutrients on immunology and inflammation, gene expression, metabolism, chronic diseases, or carcinogenesis, or a major focus on epidemiology, including intervention studies with healthy subjects and with patients, food safety, or biofunctionality of food and food components. Papers with a major focus on traditional medicine or food technology will not be accepted. Nor will case studies be accepted. Letters to the editors may be submitted. Letters are expected to provide substantive comments on papers published in the EJN. Both the letter and a reply, if appropriate, are published together whenever possible. Direct rejection: Submitted manuscripts can be rejected without detailed comments after initial review by an editor if the manuscripts are considere

The European Journal of Obstetrics & Gynecology and Reproductive Biology is the leading general clinical journal covering the continent. It publishes peer reviewed original research articles, as well as a wide range of news, book reviews, biographical, historical and educational articles and a lively correspondence section. Fields covered include obstetrics, prenatal diagnosis, maternal-fetal medicine, perinatology, general gynecology, gynecologic oncology, uro-gynecology, reproductive medicine, infertility, reproductive endocrinology, sexual medicine and reproductive ethics. The European Journal of Obstetrics & Gynecology and Reproductive Biology provides a forum for scientific and clinical professional communication in obstetrics and gynecology throughout Europe and the world.Web submission, including a new Fast track review and publication route is now available.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com